TINAMARIE SMITH: Open Payments
NPI 1679985881 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,231 in 98 payments from 25 companies in 2025. Trend: 2023 $420 · 2024 $2,047 · 2025 $2,231
Food & beverage: $2,231
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 7 | $261 |
| Novo Nordisk Inc | 12 | $256 |
| ABBVIE INC. | 10 | $179 |
| Madrigal Pharmaceuticals | 4 | $172 |
| Novartis Pharmaceuticals Corporation | 14 | $158 |
| Dexcom, Inc. | 7 | $115 |
| Gilead Sciences, Inc. | 1 | $92 |
| MIMEDX Group, Inc. | 1 | $91 |
| Corcept Therapeutics | 4 | $86 |
| Lilly USA, LLC | 5 | $85 |
Products named: MINIMED 780G, REZDIFFRA, SYNTHROID, LEQVIO, Wegovy, Dexcom G6 Transmitter, Ozempic, Livdelzi.
Industry payments across AL — which companies pay providers there.
